M28 Capital Management as of March 31, 2022
Portfolio Holdings for M28 Capital Management
M28 Capital Management holds 13 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Adagio Therapeutics (IVVD) | 26.8 | $29M | 6.4M | 4.56 | |
| Wave Life Sciences SHS (WVE) | 10.8 | $12M | 5.9M | 2.00 | |
| Rocket Pharmaceuticals (RCKT) | 10.4 | $11M | 716k | 15.86 | |
| Stoke Therapeutics (STOK) | 10.2 | $11M | 527k | 21.05 | |
| Curis Com New | 9.3 | $10M | 4.2M | 2.38 | |
| Tg Therapeutics (TGTX) | 9.2 | $10M | 1.0M | 9.51 | |
| Mirati Therapeutics | 6.3 | $6.8M | 83k | 82.22 | |
| Bridgebio Pharma (BBIO) | 4.4 | $4.7M | 466k | 10.15 | |
| Leap Therapeutics | 4.3 | $4.7M | 2.7M | 1.75 | |
| Verve Therapeutics (VERV) | 3.7 | $4.1M | 179k | 22.82 | |
| Atara Biotherapeutics | 3.3 | $3.6M | 389k | 9.29 | |
| Proqr Therapeutics N V Shs Euro (PRQR) | 0.8 | $907k | 1.0M | 0.91 | |
| Neximmune | 0.5 | $562k | 133k | 4.21 |
